Corbus Pharmaceuticals Holdings, Inc. Share Price
NASDAQ: CRBP | Micro CapCorbus Pharmaceuticals Holdings, Inc. Stock Performance
Open $9.80 | Prev. Close $9.74 | Circuit Range N/A |
Day Range $9.80 - $10.22 | Year Range $7.13 - $19.84 | Volume 16,988 |
Average Traded $10.03 |
Corbus Pharmaceuticals Holdings, Inc. Share Price Today
As of 10 August 2026, Corbus Pharmaceuticals Holdings, Inc.'s share price is $10.16. The stock opened at $9.80, compared to its previous close of $9.74. During today's trading session, Corbus Pharmaceuticals Holdings, Inc.'s share price traded between $9.80 and $10.22, with an average price of $10.01. Over the past 52 weeks, the stock has recorded a high of $19.84 and a low of $7.13. In terms of performance, Corbus Pharmaceuticals Holdings, Inc.'s share price has risen by 19.25% over the last six months and is up 7.63% on a year-on-year basis.
Corbus Pharmaceuticals Holdings, Inc. Share Price Chart
Corbus Pharmaceuticals Holdings, Inc. Stock Fundamentals & Key Indicators
Market Cap $135.30M | PE Ratio (TTM) -1.72 | Dividend Yield N/A |
EPS (TTM) $-5.90 | Revenue (TTM) N/A | Return On Equity (TTM) -53.24% |
Profit Margin N/A | Debt to Equity 0.14 | Quarterly Earnings Growth YoY -69.35% |
Corbus Pharmaceuticals Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Corbus Pharmaceuticals Holdings, Inc. Annual Profit & Loss
All figures in USD
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Corbus Pharmaceuticals Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $8.86 | $10.14 | +12.85% |
Jul 2026 | $9.30 | $8.99 | -4.31% |
Jun 2026 | $7.74 | $9.39 | +19.15% |
May 2026 | $9.70 | $7.88 | -20.43% |
Apr 2026 | $10.11 | $9.91 | +5.65% |
Mar 2026 | $8.39 | $9.38 | +10.09% |
Feb 2026 | $8.33 | $8.52 | +3.21% |
Jan 2026 | $8.19 | $8.26 | +1.68% |
Dec 2025 | $11.27 | $8.12 | -29.18% |
Nov 2025 | $12.28 | $11.46 | -5.17% |
Oct 2025 | $13.00 | $12.09 | -5.06% |
Sep 2025 | $9.62 | $12.73 | +34.90% |
CRBP Share Price FAQs
What is Corbus Pharmaceuticals Holdings, Inc. share price today?
What is the 52 week high and 52 week low of Corbus Pharmaceuticals Holdings, Inc. stock?
What is CRBP's market capitalisation today?
What is CRBP's net income for the last quarter?
What is the 5 year returns of CRBP?
What is the high & low stock price of CRBP today?
Can I buy CRBP shares in India?